(Press-News.org) An immune reaction to dystrophin, the muscle protein that is defective in patients with Duchenne muscular dystrophy, may pose a new challenge to strengthening muscles of patients with this disease, suggests a new study appearing in the October 7, 2010, issue of The New England Journal of Medicine.
Duchenne muscular dystrophy (DMD) is a hereditary and lethal neuromuscular disease characterized by progressive loss of muscle strength and integrity. Genetic information important for production of a functional dystrophin protein is deleted from the DMD gene of many patients. Studies by investigators at Nationwide Children's Hospital have examined the possibility of improving muscle strength by using modified viruses to deliver a corrected copy of the DMD gene to patients' muscles.
"DMD genes packaged into viral vectors strengthen muscles in mouse models of muscular dystrophy," said Jerry R. Mendell, MD, director, Center for Gene Therapy at The Research Institute at Nationwide Children's Hospital and one of the study authors. "In this study we attempted to translate basic research from the animal model to patients with DMD." Six boys with DMD gene deletions were treated by injecting a viral vector containing a corrected DMD gene into the biceps muscle of one arm. However, when the patients were evaluated three months later, long-term production of dystrophin protein from the corrected DMD gene was not detected.
"With one safety trial involving six patients, Drs. Mendell and Walker have provided a tremendous service to scientists advancing gene therapy research - particularly for muscular dystrophy," said Louis M. Kunkel, Ph.D., chairman of the MDA Scientific Advisory Committee. "By uncovering a somewhat surprising T cell immune response to dystrophin, they're helping investigators refine several distinct and promising approaches to treating Duchenne muscular dystrophy (DMD) by correcting or adding the dystrophin protein that is defective in the disease."
To understand why this therapy failed, the researchers measured immune responses against dystrophin. "We were concerned about immunity caused by a certain type of white blood cell called the T lymphocyte. The natural role of T cells is to protect us from infection and cancer by destroying cells that are recognized as different or foreign," said Christopher M. Walker, PhD, director, Center for Vaccines and Immunity at The Research Institute and one of the study authors. "Parts of the corrected dystrophin protein are clearly foreign because of the patient's DMD gene deletion, and so unwanted T cell immunity targeting the repaired muscle cells was a possibility."
The researchers did detect T cell immunity was against foreign segments of the corrected dystrophin protein in one patient with a large DMD gene deletion. However, stronger and faster T cell immunity was detected in a second patient with a much smaller DMD gene deletion.
"Strong, rapid immunity in the second patient with a very small DMD gene deletion was a surprise," said Dr. Walker. "The amount of corrected dystrophin protein that is foreign should also be small, and possibly ignored altogether by the T cells."
The mystery deepened further when T cell immunity to dystrophin was found to have been present in this patient even before treatment. Careful examination of the muscle revealed that the T cells present before gene therapy recognized dystrophin that is produced in a very small percentage of muscle cells that naturally self-correct the defective DMD gene. Delivery of the gene therapy vector to biceps muscle boosted and accelerated this pre-existing immune response.
"This study is significant because it documents immunity against a dystrophin protein designed to treat the disease. That may be broadly important to the entire field of gene therapy," said Dr. Mendell. "But it is even more important because of what it might mean for our basic understanding of muscle disease in DMD. We've known for a long time that T cells naturally invade muscles of DMD patients. Drugs that suppress immunity can prolong the time until they are confined to a wheel chair, but we never knew how or why this worked. This gene therapy study has lead to the new basic discovery that even small amounts of dystrophin naturally produced from self-correcting DMD genes can trigger destructive T cells, and they may target muscle cells in a process that resembles autoimmunity."
"The results from this small gene therapy trial underscore the importance of rigorous safety monitoring during all phases of clinical trials, but particularly at the early stages," said neurologist Valerie Cwik, MDA executive vice president for research and medical director. "The wealth of information about the immune system's reaction to gene therapy obtained from this study will aid in design of future clinical trials for DMD and, perhaps, other genetic neuromuscular diseases."
"Many of the on and off switches that regulate T cell immunity in humans are being identified," said Dr. Walker. "We are now attempting to manipulate these switches to enhance T cell immunity in patients with cancer and chronic viral infections. Once we understand the scope and significance of the T cell response against muscle in DMD, it may be possible to harness the same approaches to shut them off. This would move us closer to the goal of slowing muscle loss in DMD and ultimately to prevent immune responses against therapeutic dystrophin protein."
INFORMATION:
This research was made possible by support from the Muscular Dystrophy Association and Jesse's Journey, and the U.S. Department of Health and Human Services.
Gene therapy reveals unexpected immunity to dystrophin in patients with Duchenne muscular dystrophy
Natural immunity to dystrophin may contribute to muscle disease and complicate experimental therapies
2010-10-07
ELSE PRESS RELEASES FROM THIS DATE:
Drug that helps adults addicted to opioid drugs also relieves withdrawal symptoms in newborns
2010-10-07
(PHILADELPHIA) - Thousands of infants each year have exposure to opioids before they are born. Over half of these infants are born with withdrawal symptoms severe enough to require opioid replacement treatment in the nursery. Such treatment is associated with long hospital stays which interferes with maternal/infant bonding. Now, a team of researchers at Thomas Jefferson University has tested a semi-synthetic opioid they say has the potential to improve the treatment of these newborns, which could save hundreds of millions in healthcare costs annually if future tests continue ...
High risk of acute mountain sickness on Mount Kilimanjaro
2010-10-07
New Rochelle, NY, October 6, 2010 –Climbers of high peaks such as Mount Kilimanjaro are at high risk for Acute Mountain Sickness (AMS). Trekkers should not ignore AMS warning signs, which can progress to more serious medical outcomes. Mountain climbers can best minimize their risk for altitude sickness by becoming acclimatized to increased altitudes before an ascent, according to a study in the current issue of High Altitude Medicine & Biology, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article is available free online at www.liebertpub.com/ham
The ...
Novel reference material to standardize gene therapy applications
2010-10-07
New Rochelle, NY, October 6, 2010—The introduction of a new, fully characterized viral vector for use as reference material to help standardize gene therapy protocols in research applications and human clinical trials is described in an article in Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. (www.liebertpub.com). The article, which is published online ahead of print, is available free online at www.liebertpub.com/hum
The growing popularity in the gene therapy community of using recombinant adeno-associated virus (rAAV) vectors as vehicles ...
Scripps Research scientists develop novel test that identifies river blindness
2010-10-07
LA JOLLA, CA – October 6, 2010 – For Immediate Release – Scientists from The Scripps Research Institute have developed the first screening method that rapidly identifies individuals with active river blindness, a parasitic disease that afflicts an estimated 37 million people. The test could change the current strategy of mass treatment in areas where river blindness, also known as onchocerciasis, is suspected.
The study was published online on October 5, 2010, by the journal PLOS Neglected Tropical Diseases.
"A sensitive and reproducible diagnostic test for this disease ...
Neighborhoods can have depressing effect on health, according to Iowa State study
2010-10-07
AMES, Iowa -- The nation's poverty rate climbed to 14.3 percent -- the highest level since 1994 -- according to the Census Bureau's annual report on the economic well-being of U.S. households. That means one in seven Americans now live in poverty, and that may have an especially depressing effect on people living in bad neighborhoods, according to two Iowa State University researchers.
Daniel Russell, an Iowa State professor of human development and family studies; and Carolyn Cutrona, professor and chair of psychology, presented "Stressful Effects of Where You Live: ...
UD researcher on project team for NASA's first visit to the sun
2010-10-07
A University of Delaware researcher is helping to design instruments for a robotic space probe that will go where no other has gone before: the sun.
William Matthaeus, professor of physics and astronomy at UD, is involved in NASA's Solar Probe Plus project, which is slated to launch by 2018.
The unmanned spacecraft, the size of a small car, will plunge directly into the sun's atmosphere to help uncover answers to perplexing mysteries about the fiery ball of plasma at the center of our solar system.
"The experiments selected for Solar Probe Plus are specifically designed ...
Iowa State team calculates societal costs of five major crimes; finds murder at $17.25 million
2010-10-07
AMES, Iowa -- Murder takes an obvious toll on society in terms of the loss of human life, but what does it actually cost each time there's a murder? It's about $17.25 million according a recent Iowa State University study.
Matt DeLisi, an ISU associate professor of sociology and director of the criminal justice program, led a team of five Iowa State graduate students on the study of 654 convicted and incarcerated murderers. Expanding upon earlier monetization estimates, they calculated the costs of five crimes -- murder, rape, armed robbery, aggravated assault and burglary ...
Hormone acting as 'molecular glue' could boost plant immune systems
2010-10-07
EAST LANSING, Mich. — The discovery of a hormone acting like molecular glue could hold a key to bolstering plant immune systems and understanding how plants cope with environmental stress.
The study, which is featured in the Oct. 6 issue of Nature, reveals how the plant hormone jasmonate binds two proteins together – an emerging new concept in hormone biology and protein chemistry. The study also identifies the receptor's crystal structure to provide the first molecular view of how plants ward off attacks by insects and pathogens.
In short, the work explains how a highly ...
Patient-provider language barriers linked to worse diabetes control
2010-10-07
Patients who cannot discuss their diabetes with a doctor in their own language may have poorer health outcomes, even when interpreter services are available, according to a new study by researchers at UCSF and the Kaiser Permanente Division of Research.
The study found that, among Latino diabetes patients with limited English skills, those seen by non-Spanish speaking doctors were nearly twice as likely to have poor control of their blood sugar than those whose doctors spoke Spanish.
Findings will appear in the January 2011 issue of the Journal of General Internal ...
Vitamin D-ficiency common among orthopaedic surgery
2010-10-07
Forty-three percent of patients scheduled to undergo orthopaedic surgery have insufficient levels of vitamin D and two out of five of those patients had levels low enough to place them at risk for metabolic bone disease, according to a study published this month in the October 6th issue of the Journal of Bone and Joint Surgery (JBJS).
According to the National Institutes of Health (NIH) , vitamin D helps the body absorb calcium and is essential for bone growth and bone remodeling. Without sufficient vitamin D, bones can become thin, brittle or misshapen. People can obtain ...
LAST 30 PRESS RELEASES:
H.E.S.S. collaboration detects the most energetic cosmic-ray electrons and positrons ever observed
Novel supernova observations grant astronomers a peek into the cosmic past
Association of severe maternal morbidity with subsequent birth
Herodotus' theory on Armenian origins debunked by first whole-genome study
Women who suffer pregnancy complications have fewer children
Home testing kits and coordinated outreach substantially improve colorectal cancer screening rates
COVID-19 vaccine reactogenicity among young children
Generalizability of clinical trials of novel weight loss medications to the US adult population
Wildfire smoke exposure and incident dementia
Health co-benefits of China's carbon neutrality policies highlighted in new review
Key brain circuit for female sexual rejection uncovered
Electrical nerve stimulation eases long COVID pain and fatigue
ASTRO issues update to clinical guideline on radiation therapy for rectal cancer
Mount Sinai opens the Hamilton and Amabel James Center for Artificial Intelligence and Human Health to transform health care by spearheading the AI revolution
Researchers develop tools to examine neighborhood economic effects on spinal cord injury outcomes
Case Western Reserve University awarded $1.5 million to study vaginal bacterial linked to serious health risks
The next evolution of AI begins with ours
Using sunlight to recycle black plastics
ODS FeCrAl alloys endure liquid metal flow at 600 °C resembling a fusion blanket environment
A genetic key to understanding mitochondrial DNA depletion syndrome
The future of edge AI: Dye-sensitized solar cell-based synaptic device
Bats’ amazing plan B for when they can’t hear
Common thyroid medicine linked to bone loss
Vaping causes immediate effects on vascular function
A new clock to structure sleep
Study reveals new way to unlock blood-brain barrier, potentially opening doors to treat brain and nerve diseases
Viking colonizers of Iceland and nearby Faroe Islands had very different origins, study finds
One in 20 people in Canada skip doses, don’t fill prescriptions because of cost
Wildlife monitoring technologies used to intimidate and spy on women, study finds
Around 450,000 children disadvantaged by lack of school support for color blindness
[Press-News.org] Gene therapy reveals unexpected immunity to dystrophin in patients with Duchenne muscular dystrophyNatural immunity to dystrophin may contribute to muscle disease and complicate experimental therapies